Global Obesity Management
Global Obesity Management

Obesity Management Comprehensive Study by Type (Drug, Surgery), Application (Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Retail Pharmacies), Equipment Type (Fitness Equipment, Fitness Monitoring Equipment, Body Composition Analyzers, Surgical Equipment), Supplements (Protein Supplements, Fiber Supplements, Green Tea Extract, Conjugated Linoleic Acid) Players and Region - Global Market Outlook to 2025

Obesity Management Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 211 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Obesity Management Market Scope?
Obesity is a major public health problem. It is directly linked to various health conditions including diabetes, heart disease, stroke, high blood pressure, gallbladder disease, and fatty liver disease, as well as some cancers. Nearly 1 billion people worldwide are overweight or obese and the number is increasing. Weight control is not a short term thing. It is necessary to think long term about how to control weight and make lifestyle changes. Weight loss should be gradual and careful follow-up is required so as not to prevent weight gain. Changing diet, behavior, and lifestyle are the only ways to make permanent weight changes. These changes focus on changes related to eating and exercise habits. Obesity management can include lifestyle changes, medications, or surgery. The main treatment for obesity is weight loss through diet and exercise. Diet programs can lead to weight loss in the short term and long term, although combining it with exercise and counseling will produce better results.

The Obesity Management market study is being classified by Type (Drug and Surgery), by Application (Hospitals, Speciality Clinics, Ambulatory Surgical Centres and Retail Pharmacies) and major geographies with country level break-up.

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Obesity Management market throughout the predicted period.

Roche Holding AG (Switzerland), GlaxoSmithKline (United Kingdom), Orexigen Therapeutics, Inc. (United States), Arena Pharmaceuticals (United States), VIVUS (United States) and Novo Nordisk (Denmark) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Obesity Management market by Type, Application and Region.

On the basis of geography, the market of Obesity Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Growing Adoption of Online Weight Loss and Weight Management Programs
  • Increasing Rate of Childhood Obesity

Market Drivers
  • Increasing Obese Population and Sedentary Lifestyle
  • Increasing Number of Bariatric Surgeries
  • Rise in Disposable Income in Developing Economies

Opportunities
  • Rising Awareness about Maintaining Health and Fitness for Preventing Health Conditions
  • Increasing Government Initiatives for Creating Awareness among Obese Populations

Restraints
  • High Cost of Low-Calorie Diets

Challenges
  • Increasing Stringency of Regulation


Key Target Audience
Providers of Obesity Management, End-Users, Potential Investors, Market Research Firms and Others

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Drug
  • Surgery
By Application
  • Hospitals
  • Speciality Clinics
  • Ambulatory Surgical Centres
  • Retail Pharmacies
By Equipment Type
  • Fitness Equipment
  • Fitness Monitoring Equipment
  • Body Composition Analyzers
  • Surgical Equipment

By Supplements
  • Protein Supplements
  • Fiber Supplements
  • Green Tea Extract
  • Conjugated Linoleic Acid

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Obese Population and Sedentary Lifestyle
      • 3.2.2. Increasing Number of Bariatric Surgeries
      • 3.2.3. Rise in Disposable Income in Developing Economies
    • 3.3. Market Challenges
      • 3.3.1. Increasing Stringency of Regulation
    • 3.4. Market Trends
      • 3.4.1. Growing Adoption of Online Weight Loss and Weight Management Programs
      • 3.4.2. Increasing Rate of Childhood Obesity
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Obesity Management, by Type, Application, Equipment Type, Supplements and Region (value and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Obesity Management (Value)
      • 5.2.1. Global Obesity Management by: Type (Value)
        • 5.2.1.1. Drug
        • 5.2.1.2. Surgery
      • 5.2.2. Global Obesity Management by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Speciality Clinics
        • 5.2.2.3. Ambulatory Surgical Centres
        • 5.2.2.4. Retail Pharmacies
      • 5.2.3. Global Obesity Management by: Equipment Type (Value)
        • 5.2.3.1. Fitness Equipment
        • 5.2.3.2. Fitness Monitoring Equipment
        • 5.2.3.3. Body Composition Analyzers
        • 5.2.3.4. Surgical Equipment
      • 5.2.4. Global Obesity Management by: Supplements (Value)
        • 5.2.4.1. Protein Supplements
        • 5.2.4.2. Fiber Supplements
        • 5.2.4.3. Green Tea Extract
        • 5.2.4.4. Conjugated Linoleic Acid
      • 5.2.5. Global Obesity Management Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Obesity Management (Price)
      • 5.3.1. Global Obesity Management by: Type (Price)
  • 6. Obesity Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Holding AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Orexigen Therapeutics, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Arena Pharmaceuticals (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. VIVUS (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novo Nordisk (Denmark)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Obesity Management Sale, by Type, Application, Equipment Type, Supplements and Region (value and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Obesity Management (Value)
      • 7.2.1. Global Obesity Management by: Type (Value)
        • 7.2.1.1. Drug
        • 7.2.1.2. Surgery
      • 7.2.2. Global Obesity Management by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Speciality Clinics
        • 7.2.2.3. Ambulatory Surgical Centres
        • 7.2.2.4. Retail Pharmacies
      • 7.2.3. Global Obesity Management by: Equipment Type (Value)
        • 7.2.3.1. Fitness Equipment
        • 7.2.3.2. Fitness Monitoring Equipment
        • 7.2.3.3. Body Composition Analyzers
        • 7.2.3.4. Surgical Equipment
      • 7.2.4. Global Obesity Management by: Supplements (Value)
        • 7.2.4.1. Protein Supplements
        • 7.2.4.2. Fiber Supplements
        • 7.2.4.3. Green Tea Extract
        • 7.2.4.4. Conjugated Linoleic Acid
      • 7.2.5. Global Obesity Management Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Obesity Management (Price)
      • 7.3.1. Global Obesity Management by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Obesity Management: by Type(USD Million)
  • Table 2. Obesity Management Drug , by Region USD Million (2014-2019)
  • Table 3. Obesity Management Surgery , by Region USD Million (2014-2019)
  • Table 4. Obesity Management: by Application(USD Million)
  • Table 5. Obesity Management Hospitals , by Region USD Million (2014-2019)
  • Table 6. Obesity Management Speciality Clinics , by Region USD Million (2014-2019)
  • Table 7. Obesity Management Ambulatory Surgical Centres , by Region USD Million (2014-2019)
  • Table 8. Obesity Management Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 9. Obesity Management: by Equipment Type(USD Million)
  • Table 10. Obesity Management Fitness Equipment , by Region USD Million (2014-2019)
  • Table 11. Obesity Management Fitness Monitoring Equipment , by Region USD Million (2014-2019)
  • Table 12. Obesity Management Body Composition Analyzers , by Region USD Million (2014-2019)
  • Table 13. Obesity Management Surgical Equipment , by Region USD Million (2014-2019)
  • Table 14. Obesity Management: by Supplements(USD Million)
  • Table 15. Obesity Management Protein Supplements , by Region USD Million (2014-2019)
  • Table 16. Obesity Management Fiber Supplements , by Region USD Million (2014-2019)
  • Table 17. Obesity Management Green Tea Extract , by Region USD Million (2014-2019)
  • Table 18. Obesity Management Conjugated Linoleic Acid , by Region USD Million (2014-2019)
  • Table 19. South America Obesity Management, by Country USD Million (2014-2019)
  • Table 20. South America Obesity Management, by Type USD Million (2014-2019)
  • Table 21. South America Obesity Management, by Application USD Million (2014-2019)
  • Table 22. South America Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 23. South America Obesity Management, by Supplements USD Million (2014-2019)
  • Table 24. Brazil Obesity Management, by Type USD Million (2014-2019)
  • Table 25. Brazil Obesity Management, by Application USD Million (2014-2019)
  • Table 26. Brazil Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 27. Brazil Obesity Management, by Supplements USD Million (2014-2019)
  • Table 28. Argentina Obesity Management, by Type USD Million (2014-2019)
  • Table 29. Argentina Obesity Management, by Application USD Million (2014-2019)
  • Table 30. Argentina Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 31. Argentina Obesity Management, by Supplements USD Million (2014-2019)
  • Table 32. Rest of South America Obesity Management, by Type USD Million (2014-2019)
  • Table 33. Rest of South America Obesity Management, by Application USD Million (2014-2019)
  • Table 34. Rest of South America Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 35. Rest of South America Obesity Management, by Supplements USD Million (2014-2019)
  • Table 36. Asia Pacific Obesity Management, by Country USD Million (2014-2019)
  • Table 37. Asia Pacific Obesity Management, by Type USD Million (2014-2019)
  • Table 38. Asia Pacific Obesity Management, by Application USD Million (2014-2019)
  • Table 39. Asia Pacific Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 40. Asia Pacific Obesity Management, by Supplements USD Million (2014-2019)
  • Table 41. China Obesity Management, by Type USD Million (2014-2019)
  • Table 42. China Obesity Management, by Application USD Million (2014-2019)
  • Table 43. China Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 44. China Obesity Management, by Supplements USD Million (2014-2019)
  • Table 45. Japan Obesity Management, by Type USD Million (2014-2019)
  • Table 46. Japan Obesity Management, by Application USD Million (2014-2019)
  • Table 47. Japan Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 48. Japan Obesity Management, by Supplements USD Million (2014-2019)
  • Table 49. India Obesity Management, by Type USD Million (2014-2019)
  • Table 50. India Obesity Management, by Application USD Million (2014-2019)
  • Table 51. India Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 52. India Obesity Management, by Supplements USD Million (2014-2019)
  • Table 53. South Korea Obesity Management, by Type USD Million (2014-2019)
  • Table 54. South Korea Obesity Management, by Application USD Million (2014-2019)
  • Table 55. South Korea Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 56. South Korea Obesity Management, by Supplements USD Million (2014-2019)
  • Table 57. Taiwan Obesity Management, by Type USD Million (2014-2019)
  • Table 58. Taiwan Obesity Management, by Application USD Million (2014-2019)
  • Table 59. Taiwan Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 60. Taiwan Obesity Management, by Supplements USD Million (2014-2019)
  • Table 61. Australia Obesity Management, by Type USD Million (2014-2019)
  • Table 62. Australia Obesity Management, by Application USD Million (2014-2019)
  • Table 63. Australia Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 64. Australia Obesity Management, by Supplements USD Million (2014-2019)
  • Table 65. Rest of Asia-Pacific Obesity Management, by Type USD Million (2014-2019)
  • Table 66. Rest of Asia-Pacific Obesity Management, by Application USD Million (2014-2019)
  • Table 67. Rest of Asia-Pacific Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 68. Rest of Asia-Pacific Obesity Management, by Supplements USD Million (2014-2019)
  • Table 69. Europe Obesity Management, by Country USD Million (2014-2019)
  • Table 70. Europe Obesity Management, by Type USD Million (2014-2019)
  • Table 71. Europe Obesity Management, by Application USD Million (2014-2019)
  • Table 72. Europe Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 73. Europe Obesity Management, by Supplements USD Million (2014-2019)
  • Table 74. Germany Obesity Management, by Type USD Million (2014-2019)
  • Table 75. Germany Obesity Management, by Application USD Million (2014-2019)
  • Table 76. Germany Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 77. Germany Obesity Management, by Supplements USD Million (2014-2019)
  • Table 78. France Obesity Management, by Type USD Million (2014-2019)
  • Table 79. France Obesity Management, by Application USD Million (2014-2019)
  • Table 80. France Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 81. France Obesity Management, by Supplements USD Million (2014-2019)
  • Table 82. Italy Obesity Management, by Type USD Million (2014-2019)
  • Table 83. Italy Obesity Management, by Application USD Million (2014-2019)
  • Table 84. Italy Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 85. Italy Obesity Management, by Supplements USD Million (2014-2019)
  • Table 86. United Kingdom Obesity Management, by Type USD Million (2014-2019)
  • Table 87. United Kingdom Obesity Management, by Application USD Million (2014-2019)
  • Table 88. United Kingdom Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 89. United Kingdom Obesity Management, by Supplements USD Million (2014-2019)
  • Table 90. Netherlands Obesity Management, by Type USD Million (2014-2019)
  • Table 91. Netherlands Obesity Management, by Application USD Million (2014-2019)
  • Table 92. Netherlands Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 93. Netherlands Obesity Management, by Supplements USD Million (2014-2019)
  • Table 94. Rest of Europe Obesity Management, by Type USD Million (2014-2019)
  • Table 95. Rest of Europe Obesity Management, by Application USD Million (2014-2019)
  • Table 96. Rest of Europe Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 97. Rest of Europe Obesity Management, by Supplements USD Million (2014-2019)
  • Table 98. MEA Obesity Management, by Country USD Million (2014-2019)
  • Table 99. MEA Obesity Management, by Type USD Million (2014-2019)
  • Table 100. MEA Obesity Management, by Application USD Million (2014-2019)
  • Table 101. MEA Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 102. MEA Obesity Management, by Supplements USD Million (2014-2019)
  • Table 103. Middle East Obesity Management, by Type USD Million (2014-2019)
  • Table 104. Middle East Obesity Management, by Application USD Million (2014-2019)
  • Table 105. Middle East Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 106. Middle East Obesity Management, by Supplements USD Million (2014-2019)
  • Table 107. Africa Obesity Management, by Type USD Million (2014-2019)
  • Table 108. Africa Obesity Management, by Application USD Million (2014-2019)
  • Table 109. Africa Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 110. Africa Obesity Management, by Supplements USD Million (2014-2019)
  • Table 111. North America Obesity Management, by Country USD Million (2014-2019)
  • Table 112. North America Obesity Management, by Type USD Million (2014-2019)
  • Table 113. North America Obesity Management, by Application USD Million (2014-2019)
  • Table 114. North America Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 115. North America Obesity Management, by Supplements USD Million (2014-2019)
  • Table 116. United States Obesity Management, by Type USD Million (2014-2019)
  • Table 117. United States Obesity Management, by Application USD Million (2014-2019)
  • Table 118. United States Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 119. United States Obesity Management, by Supplements USD Million (2014-2019)
  • Table 120. Canada Obesity Management, by Type USD Million (2014-2019)
  • Table 121. Canada Obesity Management, by Application USD Million (2014-2019)
  • Table 122. Canada Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 123. Canada Obesity Management, by Supplements USD Million (2014-2019)
  • Table 124. Mexico Obesity Management, by Type USD Million (2014-2019)
  • Table 125. Mexico Obesity Management, by Application USD Million (2014-2019)
  • Table 126. Mexico Obesity Management, by Equipment Type USD Million (2014-2019)
  • Table 127. Mexico Obesity Management, by Supplements USD Million (2014-2019)
  • Table 128. Obesity Management: by Type(USD/Units)
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Obesity Management: by Type(USD Million)
  • Table 136. Obesity Management Drug , by Region USD Million (2020-2025)
  • Table 137. Obesity Management Surgery , by Region USD Million (2020-2025)
  • Table 138. Obesity Management: by Application(USD Million)
  • Table 139. Obesity Management Hospitals , by Region USD Million (2020-2025)
  • Table 140. Obesity Management Speciality Clinics , by Region USD Million (2020-2025)
  • Table 141. Obesity Management Ambulatory Surgical Centres , by Region USD Million (2020-2025)
  • Table 142. Obesity Management Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 143. Obesity Management: by Equipment Type(USD Million)
  • Table 144. Obesity Management Fitness Equipment , by Region USD Million (2020-2025)
  • Table 145. Obesity Management Fitness Monitoring Equipment , by Region USD Million (2020-2025)
  • Table 146. Obesity Management Body Composition Analyzers , by Region USD Million (2020-2025)
  • Table 147. Obesity Management Surgical Equipment , by Region USD Million (2020-2025)
  • Table 148. Obesity Management: by Supplements(USD Million)
  • Table 149. Obesity Management Protein Supplements , by Region USD Million (2020-2025)
  • Table 150. Obesity Management Fiber Supplements , by Region USD Million (2020-2025)
  • Table 151. Obesity Management Green Tea Extract , by Region USD Million (2020-2025)
  • Table 152. Obesity Management Conjugated Linoleic Acid , by Region USD Million (2020-2025)
  • Table 153. South America Obesity Management, by Country USD Million (2020-2025)
  • Table 154. South America Obesity Management, by Type USD Million (2020-2025)
  • Table 155. South America Obesity Management, by Application USD Million (2020-2025)
  • Table 156. South America Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 157. South America Obesity Management, by Supplements USD Million (2020-2025)
  • Table 158. Brazil Obesity Management, by Type USD Million (2020-2025)
  • Table 159. Brazil Obesity Management, by Application USD Million (2020-2025)
  • Table 160. Brazil Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 161. Brazil Obesity Management, by Supplements USD Million (2020-2025)
  • Table 162. Argentina Obesity Management, by Type USD Million (2020-2025)
  • Table 163. Argentina Obesity Management, by Application USD Million (2020-2025)
  • Table 164. Argentina Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 165. Argentina Obesity Management, by Supplements USD Million (2020-2025)
  • Table 166. Rest of South America Obesity Management, by Type USD Million (2020-2025)
  • Table 167. Rest of South America Obesity Management, by Application USD Million (2020-2025)
  • Table 168. Rest of South America Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 169. Rest of South America Obesity Management, by Supplements USD Million (2020-2025)
  • Table 170. Asia Pacific Obesity Management, by Country USD Million (2020-2025)
  • Table 171. Asia Pacific Obesity Management, by Type USD Million (2020-2025)
  • Table 172. Asia Pacific Obesity Management, by Application USD Million (2020-2025)
  • Table 173. Asia Pacific Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 174. Asia Pacific Obesity Management, by Supplements USD Million (2020-2025)
  • Table 175. China Obesity Management, by Type USD Million (2020-2025)
  • Table 176. China Obesity Management, by Application USD Million (2020-2025)
  • Table 177. China Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 178. China Obesity Management, by Supplements USD Million (2020-2025)
  • Table 179. Japan Obesity Management, by Type USD Million (2020-2025)
  • Table 180. Japan Obesity Management, by Application USD Million (2020-2025)
  • Table 181. Japan Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 182. Japan Obesity Management, by Supplements USD Million (2020-2025)
  • Table 183. India Obesity Management, by Type USD Million (2020-2025)
  • Table 184. India Obesity Management, by Application USD Million (2020-2025)
  • Table 185. India Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 186. India Obesity Management, by Supplements USD Million (2020-2025)
  • Table 187. South Korea Obesity Management, by Type USD Million (2020-2025)
  • Table 188. South Korea Obesity Management, by Application USD Million (2020-2025)
  • Table 189. South Korea Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 190. South Korea Obesity Management, by Supplements USD Million (2020-2025)
  • Table 191. Taiwan Obesity Management, by Type USD Million (2020-2025)
  • Table 192. Taiwan Obesity Management, by Application USD Million (2020-2025)
  • Table 193. Taiwan Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 194. Taiwan Obesity Management, by Supplements USD Million (2020-2025)
  • Table 195. Australia Obesity Management, by Type USD Million (2020-2025)
  • Table 196. Australia Obesity Management, by Application USD Million (2020-2025)
  • Table 197. Australia Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 198. Australia Obesity Management, by Supplements USD Million (2020-2025)
  • Table 199. Rest of Asia-Pacific Obesity Management, by Type USD Million (2020-2025)
  • Table 200. Rest of Asia-Pacific Obesity Management, by Application USD Million (2020-2025)
  • Table 201. Rest of Asia-Pacific Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 202. Rest of Asia-Pacific Obesity Management, by Supplements USD Million (2020-2025)
  • Table 203. Europe Obesity Management, by Country USD Million (2020-2025)
  • Table 204. Europe Obesity Management, by Type USD Million (2020-2025)
  • Table 205. Europe Obesity Management, by Application USD Million (2020-2025)
  • Table 206. Europe Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 207. Europe Obesity Management, by Supplements USD Million (2020-2025)
  • Table 208. Germany Obesity Management, by Type USD Million (2020-2025)
  • Table 209. Germany Obesity Management, by Application USD Million (2020-2025)
  • Table 210. Germany Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 211. Germany Obesity Management, by Supplements USD Million (2020-2025)
  • Table 212. France Obesity Management, by Type USD Million (2020-2025)
  • Table 213. France Obesity Management, by Application USD Million (2020-2025)
  • Table 214. France Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 215. France Obesity Management, by Supplements USD Million (2020-2025)
  • Table 216. Italy Obesity Management, by Type USD Million (2020-2025)
  • Table 217. Italy Obesity Management, by Application USD Million (2020-2025)
  • Table 218. Italy Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 219. Italy Obesity Management, by Supplements USD Million (2020-2025)
  • Table 220. United Kingdom Obesity Management, by Type USD Million (2020-2025)
  • Table 221. United Kingdom Obesity Management, by Application USD Million (2020-2025)
  • Table 222. United Kingdom Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 223. United Kingdom Obesity Management, by Supplements USD Million (2020-2025)
  • Table 224. Netherlands Obesity Management, by Type USD Million (2020-2025)
  • Table 225. Netherlands Obesity Management, by Application USD Million (2020-2025)
  • Table 226. Netherlands Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 227. Netherlands Obesity Management, by Supplements USD Million (2020-2025)
  • Table 228. Rest of Europe Obesity Management, by Type USD Million (2020-2025)
  • Table 229. Rest of Europe Obesity Management, by Application USD Million (2020-2025)
  • Table 230. Rest of Europe Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 231. Rest of Europe Obesity Management, by Supplements USD Million (2020-2025)
  • Table 232. MEA Obesity Management, by Country USD Million (2020-2025)
  • Table 233. MEA Obesity Management, by Type USD Million (2020-2025)
  • Table 234. MEA Obesity Management, by Application USD Million (2020-2025)
  • Table 235. MEA Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 236. MEA Obesity Management, by Supplements USD Million (2020-2025)
  • Table 237. Middle East Obesity Management, by Type USD Million (2020-2025)
  • Table 238. Middle East Obesity Management, by Application USD Million (2020-2025)
  • Table 239. Middle East Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 240. Middle East Obesity Management, by Supplements USD Million (2020-2025)
  • Table 241. Africa Obesity Management, by Type USD Million (2020-2025)
  • Table 242. Africa Obesity Management, by Application USD Million (2020-2025)
  • Table 243. Africa Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 244. Africa Obesity Management, by Supplements USD Million (2020-2025)
  • Table 245. North America Obesity Management, by Country USD Million (2020-2025)
  • Table 246. North America Obesity Management, by Type USD Million (2020-2025)
  • Table 247. North America Obesity Management, by Application USD Million (2020-2025)
  • Table 248. North America Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 249. North America Obesity Management, by Supplements USD Million (2020-2025)
  • Table 250. United States Obesity Management, by Type USD Million (2020-2025)
  • Table 251. United States Obesity Management, by Application USD Million (2020-2025)
  • Table 252. United States Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 253. United States Obesity Management, by Supplements USD Million (2020-2025)
  • Table 254. Canada Obesity Management, by Type USD Million (2020-2025)
  • Table 255. Canada Obesity Management, by Application USD Million (2020-2025)
  • Table 256. Canada Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 257. Canada Obesity Management, by Supplements USD Million (2020-2025)
  • Table 258. Mexico Obesity Management, by Type USD Million (2020-2025)
  • Table 259. Mexico Obesity Management, by Application USD Million (2020-2025)
  • Table 260. Mexico Obesity Management, by Equipment Type USD Million (2020-2025)
  • Table 261. Mexico Obesity Management, by Supplements USD Million (2020-2025)
  • Table 262. Obesity Management: by Type(USD/Units)
  • Table 263. Research Programs/Design for This Report
  • Table 264. Key Data Information from Secondary Sources
  • Table 265. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Obesity Management: by Type USD Million (2014-2019)
  • Figure 5. Global Obesity Management: by Application USD Million (2014-2019)
  • Figure 6. Global Obesity Management: by Equipment Type USD Million (2014-2019)
  • Figure 7. Global Obesity Management: by Supplements USD Million (2014-2019)
  • Figure 8. South America Obesity Management Share (%), by Country
  • Figure 9. Asia Pacific Obesity Management Share (%), by Country
  • Figure 10. Europe Obesity Management Share (%), by Country
  • Figure 11. MEA Obesity Management Share (%), by Country
  • Figure 12. North America Obesity Management Share (%), by Country
  • Figure 13. Global Obesity Management: by Type USD/Units (2014-2019)
  • Figure 14. Global Obesity Management share by Players 2019 (%)
  • Figure 15. Global Obesity Management share by Players (Top 3) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. Roche Holding AG (Switzerland) Revenue: by Geography 2019
  • Figure 19. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2019
  • Figure 21. Orexigen Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Orexigen Therapeutics, Inc. (United States) Revenue: by Geography 2019
  • Figure 23. Arena Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 24. Arena Pharmaceuticals (United States) Revenue: by Geography 2019
  • Figure 25. VIVUS (United States) Revenue, Net Income and Gross profit
  • Figure 26. VIVUS (United States) Revenue: by Geography 2019
  • Figure 27. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 28. Novo Nordisk (Denmark) Revenue: by Geography 2019
  • Figure 29. Global Obesity Management: by Type USD Million (2020-2025)
  • Figure 30. Global Obesity Management: by Application USD Million (2020-2025)
  • Figure 31. Global Obesity Management: by Equipment Type USD Million (2020-2025)
  • Figure 32. Global Obesity Management: by Supplements USD Million (2020-2025)
  • Figure 33. South America Obesity Management Share (%), by Country
  • Figure 34. Asia Pacific Obesity Management Share (%), by Country
  • Figure 35. Europe Obesity Management Share (%), by Country
  • Figure 36. MEA Obesity Management Share (%), by Country
  • Figure 37. North America Obesity Management Share (%), by Country
  • Figure 38. Global Obesity Management: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Roche Holding AG (Switzerland)
  • GlaxoSmithKline (United Kingdom)
  • Orexigen Therapeutics, Inc. (United States)
  • Arena Pharmaceuticals (United States)
  • VIVUS (United States)
  • Novo Nordisk (Denmark)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation